JP2005534648A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005534648A5 JP2005534648A5 JP2004510702A JP2004510702A JP2005534648A5 JP 2005534648 A5 JP2005534648 A5 JP 2005534648A5 JP 2004510702 A JP2004510702 A JP 2004510702A JP 2004510702 A JP2004510702 A JP 2004510702A JP 2005534648 A5 JP2005534648 A5 JP 2005534648A5
- Authority
- JP
- Japan
- Prior art keywords
- flt
- agent
- medicament
- agonist
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38663702P | 2002-06-05 | 2002-06-05 | |
| US60/386,637 | 2002-06-05 | ||
| PCT/US2003/017591 WO2003103581A2 (en) | 2002-06-05 | 2003-06-05 | Compositions and methods for liver growth and liver protection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010038622A Division JP2010159266A (ja) | 2002-06-05 | 2010-02-24 | 肝成長及び肝保護のための組成物と方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005534648A JP2005534648A (ja) | 2005-11-17 |
| JP2005534648A5 true JP2005534648A5 (https=) | 2006-07-20 |
| JP5111729B2 JP5111729B2 (ja) | 2013-01-09 |
Family
ID=29736189
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004510702A Expired - Fee Related JP5111729B2 (ja) | 2002-06-05 | 2003-06-05 | 肝成長及び肝保護のための組成物と方法 |
| JP2010038622A Withdrawn JP2010159266A (ja) | 2002-06-05 | 2010-02-24 | 肝成長及び肝保護のための組成物と方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010038622A Withdrawn JP2010159266A (ja) | 2002-06-05 | 2010-02-24 | 肝成長及び肝保護のための組成物と方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7700571B2 (https=) |
| EP (2) | EP1531676B1 (https=) |
| JP (2) | JP5111729B2 (https=) |
| AU (1) | AU2003251397B2 (https=) |
| CA (1) | CA2486270C (https=) |
| IL (2) | IL165392A0 (https=) |
| WO (1) | WO2003103581A2 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7109167B2 (en) | 2000-06-02 | 2006-09-19 | Bracco International B.V. | Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| US8263739B2 (en) | 2000-06-02 | 2012-09-11 | Bracco Suisse Sa | Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| US20050123925A1 (en) | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US7794693B2 (en) | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
| US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
| US7211240B2 (en) | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
| AU2003278807A1 (en) | 2002-03-01 | 2004-08-13 | Bracco International B.V. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| IL165392A0 (en) * | 2002-06-05 | 2006-01-15 | Genentech Inc | Compositions and methods for liver growth and liver protection |
| CA2553303C (en) * | 2004-01-14 | 2014-06-10 | Novahep Ab | Human hepatic progenitor cells and methods of use thereof |
| US8070703B2 (en) * | 2004-03-10 | 2011-12-06 | Vision Quest Industries Incorporated | Electrically stimulating orthotic device and segmented liner |
| LT1781698T (lt) | 2004-07-20 | 2016-09-26 | Genentech, Inc. | Į angiopoetiną panašaus baltymo 4 kompozicijos ir panaudojimo būdai |
| MX2007011735A (es) | 2005-03-24 | 2008-03-14 | Thrombogenics Nv | Anticuerpo anti-plgf novedoso. |
| JP2008537551A (ja) | 2005-03-31 | 2008-09-18 | カランド ファーマシューティカルズ， インコーポレイテッド | リボヌクレオチドレダクターゼサブユニット２の阻害剤およびその使用 |
| EP1904095B1 (en) | 2005-06-30 | 2013-05-29 | VIB, vzw | Treatment of liver cirrhosis and its complications |
| BRPI0621124A2 (pt) | 2005-12-22 | 2011-11-29 | Genentech Inc | métodos para recuperação de uma proteìna de ligação à heparina |
| BRPI0709411A2 (pt) * | 2006-03-27 | 2011-07-12 | Genentech Inc | método para tratamento de uma doença renal |
| US8685730B2 (en) * | 2006-05-02 | 2014-04-01 | Wisconsin Alumni Research Foundation | Methods and devices for differentiating pluripotent stem cells into cells of the pancreatic lineage |
| CN101250498B (zh) * | 2008-04-07 | 2010-06-09 | 南通大学附属医院 | 用载肝细胞生长因子聚乳酸-o-羧甲基壳聚糖纳米粒子的肝细胞培养方法 |
| CN102239178B (zh) | 2008-10-02 | 2017-06-23 | Vib研究所 | 抑制PlGF以治疗费城染色体阳性白血病 |
| CA2816593C (en) * | 2010-11-09 | 2021-05-25 | Shahin Rafii | Methods for organ regeneration |
| PL2508207T3 (pl) * | 2011-03-31 | 2013-09-30 | Bioalliance Pharma | Nanocząsteczki zawierające chemioterapeutyczny lek przeciwnowotworowy |
| WO2013033513A1 (en) | 2011-08-31 | 2013-03-07 | University Of Georgia Research Foundation, Inc. | Apoptosis-targeting nanoparticles |
| AU2012321082B2 (en) | 2011-12-01 | 2015-03-12 | Oxurion NV | Improving trabeculectomy outcome |
| JP6356614B2 (ja) | 2012-02-17 | 2018-07-11 | ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド | 薬剤のミトコンドリア輸送のためのナノ粒子 |
| US10398663B2 (en) | 2014-03-14 | 2019-09-03 | University Of Georgia Research Foundation, Inc. | Mitochondrial delivery of 3-bromopyruvate |
| KR102461927B1 (ko) * | 2016-02-17 | 2022-10-31 | 차의과학대학교 산학협력단 | 이식용 줄기세포 및 이를 포함하는 혈관신생의 유도 또는 촉진을 위한 이식용 약학 조성물 |
| CN114224893B (zh) * | 2022-01-25 | 2023-06-06 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 喹唑啉衍生物在制备防治砷致肝损伤药物中的用途 |
| CN116869986B (zh) * | 2023-07-13 | 2025-12-02 | 南方医科大学 | β-羟基丁酸在制备促进肝细胞增殖和肝脏再生产品方面的应用 |
| TWI909652B (zh) | 2023-08-31 | 2025-12-21 | 日商肽夢想股份有限公司 | 具有ｖｅｇｆｒ－２促效劑活性的肽複合物 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| NZ201918A (en) | 1981-09-18 | 1987-04-30 | Genentech Inc | N-terminal methionyl analogues of bovine growth hormone |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4889818A (en) | 1986-08-22 | 1989-12-26 | Cetus Corporation | Purified thermostable enzyme |
| US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
| US5217999A (en) | 1987-12-24 | 1993-06-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Styryl compounds which inhibit EGF receptor protein tyrosine kinase |
| WO1991015495A1 (en) | 1990-04-02 | 1991-10-17 | Pfizer Inc. | Benzylphosphonic acid tyrosine kinase inhibitors |
| US5302606A (en) | 1990-04-16 | 1994-04-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase |
| FI935279L (fi) | 1991-05-29 | 1993-11-26 | Pfizer | Tricykliska polyhydroxyltyrosinkinasininhibitorer |
| US5227158A (en) | 1991-06-10 | 1993-07-13 | Genentech, Inc. | Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon |
| GB9300059D0 (en) | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
| WO1994003427A1 (en) | 1992-08-06 | 1994-02-17 | Warner-Lambert Company | 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| US6107046A (en) | 1992-10-09 | 2000-08-22 | Orion Corporation | Antibodies to Flt4, a receptor tyrosine kinase and uses thereof |
| US5330992A (en) | 1992-10-23 | 1994-07-19 | Sterling Winthrop Inc. | 1-cyclopropyl-4-pyridyl-quinolinones |
| GB9226855D0 (en) | 1992-12-23 | 1993-02-17 | Erba Carlo Spa | Vinylene-azaindole derivatives and process for their preparation |
| US6020473A (en) | 1995-08-25 | 2000-02-01 | Genentech, Inc. | Nucleic acids encoding variants of vascular endothelial cell growth factor |
| ES2202469T5 (es) | 1995-09-08 | 2011-06-06 | Genentech, Inc. | Proteína relacionada con el vegf. |
| US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
| ATE420177T1 (de) | 1999-04-16 | 2009-01-15 | Genentech Inc | Vaskuläre endothelzellen wachstumsfaktor (vegf) varianten und dessen verwendungen |
| AU5023300A (en) | 1999-05-20 | 2000-12-12 | Scios Inc. | Vascular endothelial growth factor variants |
| US20020164310A1 (en) | 2001-03-02 | 2002-11-07 | Mgvs Ltd. | Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension |
| US6659223B2 (en) * | 2001-10-05 | 2003-12-09 | Collins & Aikman Products Co. | Sound attenuating material for use within vehicles and methods of making same |
| IL165392A0 (en) | 2002-06-05 | 2006-01-15 | Genentech Inc | Compositions and methods for liver growth and liver protection |
-
2003
- 2003-06-05 IL IL16539203A patent/IL165392A0/xx unknown
- 2003-06-05 AU AU2003251397A patent/AU2003251397B2/en not_active Ceased
- 2003-06-05 CA CA2486270A patent/CA2486270C/en not_active Expired - Fee Related
- 2003-06-05 US US10/455,470 patent/US7700571B2/en not_active Expired - Fee Related
- 2003-06-05 EP EP03757334.2A patent/EP1531676B1/en not_active Expired - Lifetime
- 2003-06-05 WO PCT/US2003/017591 patent/WO2003103581A2/en not_active Ceased
- 2003-06-05 EP EP11180450A patent/EP2430923A1/en not_active Withdrawn
- 2003-06-05 JP JP2004510702A patent/JP5111729B2/ja not_active Expired - Fee Related
-
2004
- 2004-11-25 IL IL165392A patent/IL165392A/en active IP Right Grant
-
2006
- 2006-09-25 US US11/535,049 patent/US7709455B2/en not_active Expired - Fee Related
-
2010
- 2010-02-24 JP JP2010038622A patent/JP2010159266A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005534648A5 (https=) | ||
| Shariat et al. | Adenovirus-mediated transfer of inducible caspases: a novel “death switch” gene therapeutic approach to prostate cancer | |
| Gonzalez-Barrios et al. | Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats | |
| Tong et al. | Eye drop delivery of nano‐polymeric micelle formulated genes with cornea‐specific promoters | |
| Eliaz et al. | Robust and prolonged gene expression from injectable polymeric implants | |
| Trinh et al. | Pax-6 activates endogenous proglucagon gene expression in the rodent gastrointestinal epithelium | |
| Duan et al. | Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C | |
| CA2354029C (en) | Gene therapy for cardiomyopathy | |
| JPWO2001026694A1 (ja) | 心筋症遺伝子治療 | |
| Wang et al. | Construction of exosome-loaded LL-37 and its protection against zika virus infection | |
| JP4219335B2 (ja) | インターフェロンβのような分泌タンパク質をコードする遺伝子を使用する治療のための方法および組成物 | |
| US6696423B1 (en) | Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta | |
| WO1997015668A2 (en) | Methods and compositions comprising glut-2 and glut-2 chimeras | |
| Jiang et al. | Hypoxic response elements control expression of human vascular endothelial growth factor165 genes transferred to ischemia myocardium in vivo and in vitro | |
| CN108079316A (zh) | 干扰fxr表达试剂在制备抗肝纤维化药物中的应用 | |
| EP1594549B1 (en) | Hypoxia inducible vegf plasmid for ischemic disease | |
| RU2522810C1 (ru) | Носитель для направленной доставки нуклеиновых кислот в клетки, экспрессирующие рецептор cxcr4 | |
| US20060193832A1 (en) | Use of the sodium iodine symporter to effect uptake of iodine | |
| Zhang et al. | Cell-specific viral gene therapy of a Hurthle cell tumor | |
| Bowles et al. | Prospects for adenovirus-mediated gene therapy of inherited diseases of the myocardium | |
| Lee et al. | Usefulness of intra-arterial embolization method using gelfoam particles in effective gene transduction of adenoviral vector for liver-directed gene therapy: an preliminary animal study in dogs | |
| EP1679375A1 (en) | Methods and compositions for cancer therapies using genes encoding interferon-beta | |
| MXPA00002101A (es) | Metodos y composiciones para terapias que utilizan genes que codifican proteinas secretadas como beta-interferon | |
| Parikh et al. | 294. Herpes Simplex Virus Mediated Oncolysis is an Effective Intratumoral Therapy in High-Risk Neuroblastoma Tumor Models | |
| Wacheck | Poster Sessions Friday 22 November s145 |